Summary
The present experiments were performed in order to investigate the effects of dopamine(DA)ergic drugs on the concentrations of extracellular glutamate (GLU) in the striatum of non-anaesthetised, freely moving rats by using microdialysis and to get further information about the interactions between glutamatergic and dopaminergic pathways. GLU was determined after pre-column derivatisation with o-phthaldialdehyde by HPLC and fluorescence detection. For increasing the fraction of extracellular GLU which is of neuronal origin, an enhanced release of this neurotransmitter was evoked by 100mM K+ administered via the dialysis probe. This stimulation was applied twice in each experiment, at the second time after administration of a subcutaneously (s.c.) given DAergic drug. For basal conditions, a perfusion fluid containing 148.2mM Na+, 4mM K+, 1.2mM Ca2+ was used, for conditions of stimulation with 100mM K+ the Na+ concentration was reduced correspondingly. Activation of the D1 receptor with the selective D1 sector agonist SKF 38393 ((+/−) 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol) 15 mg/kg) failed to influence the stimulated release of GLU, and neither a combination of the selective D2 antagonist (−)sulpiride (150 mg/kg) with the mixed D1/D2 agonist apomorphine (1 mg/kg), nor a combination of sulphide (150 mg/kg) with SKF 38393 (15 mg/kg) were effective. Also the two selective D2 agonists quinpirole (0.5 mg/kg) or talipexole (50μg/kg) had no significant influence on the release of GLU. The results suggest that DA receptor agonists have less effect on the K+-stimulated GLU-release than might be expected from in vitro studies or behavioral experiments (Kornhuber and Kornhuber, 1986).
Similar content being viewed by others
References
Andén NE, Golembiowska-Nikitin K, Thornström U (1982) Selective stimulation of dopamine and noradrenalin autoreceptors by BHT 920 and BHT 933, respectively. Naunyn-Schmiedebergs Arch Pharmacol 321: 100–104
Arbuthnott GW, Brown JR., MacLeod NK, Mitchell R, Wright AK (1987) The action of dopamine on synaptic transmission through the striatum. In: Sandler M, Feuerstein C, Scatton B (eds) Neurotransmitter interaction in the basal ganglia. Raven Press, New York, pp 71–81
Bolam JP, Izzo PN (1987) Possible sites of transmitter interaction in the neostriatum: an anatomical approach. In: Sandler M, Feuerstein C, Scatton B (eds) Neurotransmitter interaction in the basal ganglia. Raven Press, New York, pp 47–58
Bordi F, Meller E (1989) Enhanced behavioral stereotypies elicited by intrastriatal injection of D1 and D2 dopamine agonists in intact rats. Brain Res 504: 276–283
Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. TINS 13: 272–276
Eilam D, Szechtman H (1989) Biphasic effect of D2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161: 151–157
Fifkova E, Marsala J (1967) Stereotaxic atlases for the cat, rabbit and rat. In: Bures J, Petran M, Zachar J (eds) Electrophysiological methods in biological research. Academia, Publishing house of the Academy of Science, Prague, and Academical Press, New York London, pp 653–722
Gaddum JH (1961) Push-pull cannulae. J Physiol (London) 155: 1–2
Girault JA, Barbeito L, Spampinato U, Gozlan H, Glowinski J, Besson MJ (1986) In vivo release of endogenous amino acids from the rat striatum: further evidence for a role of glutamate and aspartate in corticostriatal neurotransmission. J Neurochem 47: 98–1060
Glowinski J, Cheramy A, Giorguieff MF (1979) In vivo and in vitro release of dopamine. In: Horn AS, Korf J, Westerink BHC (eds) The neurobiology of dopamine, vol 15. Academic Press, London New York, pp 199–217
Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. TINS 13: 244–254
Imperato A, DiChiara G (1984) Trans-striatal dialysis coupled to reversed phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J Neurosci 4: 966–977
Imperato A, Mulas A, DiChiara G (1987) The D1 antagonist SCH 23390 stimulates while D1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur J Pharmacol 142: 177–181
Imperato A, Tanda G, Frau R, DiChiara G (1988) Pharamacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245: 257–264
Kornhuber J, Kornhuber ME (1986) Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci 39: 669–674
Kropf W, Kuschinsky K (1991) Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Neuropharmacology 30: 953–960
Lindroth P, Mopper K (1979) High performance liquid chromatographic determination of subpicomols amounts of amino acids by precolumn fluorescence derivatisation with o-phthaldialdehyd. Anal Chem 51: 1667–1674
Maura G, Giardi A, Raiteri M (1988) Release-regulating D2 dopamine receptors are located in striatal glutamatergic nerve terminals. J Pharmacol Exp Ther 247: 680–684
Molloy AG, Waddington JL (1984) Dopaminergic behavior stereospecifically promoted by the D1 agonist (R)-SKF 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82: 409–410
Paulsen RE, Fonnum F (1989) Role of glia cells for the basal and Ca2+ dependent K+ evoked release of transmitter amino acids investigated by microdialysis. J Neurochem 52: 1823–1829
Paulsen RE, Contestabile A, Villani L, Fonnum F (1988) The effect of fluorocitrate on transmitter amino acid release from rat striatal slices. Neurochem Res 13: 637–641
Rowlands GJ, Roberts PJ (1980) Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro. Eur J Pharmacol 62: 241–242
Stoof JC, Kebabian J (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35: 2281–2296
Tsurata K, Frey EA, Grewe CW, Cote TE, Eskay RL, Kebabian JW (1981) Evidence that LY141865 specifically stimulates the D1 dopamine receptor. Nature 292: 463–465
Ungerstedt U (1984) Measurement of neurotransmitter release by intercranial dialysis. In: Marsden CA (ed) Measurement of neurotransmitter release in vivo. Wiley, New York, pp 81–105
Ungerstedt U, Forster C, Herrera-Marschitz M, Hoffmann U, Jungnelius U, Tossman U, Zetterström T (1982) Brain dialysis—a new in vivo technique for studying neurotrans- mitter release and metabolism. Neurosci Lett [Suppl 10]: 493
Waldmeier PC, Feldtrauer JJ, Stöcklin K (1991) Baclofen and the GABAB antagonist CGP 35348, do not affect extracellular GABA, GLU and ASP in the striatum of conscious rats after systemic administration. In: Rollema H, Westerink BHC, de Vries JB (eds) Monitoring molecules in neuroscience. Proc 5th Int Conference on In Vivo Methods, pp 425–427
Welsch-Kunze S, Kleim J, Dietze S, Kuschinsky K (1992) Recordings of extracellular glutamate and GABA in the striatum of non-anaesthetised rats: K+ stimulation, its Ca2+ dependency and lack of effects of drugs acting on dopamine receptors. Drug Res (in press)
Westerink BHC, de Vries JB (1988) Characterisation of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J Neurochem 51: 683–687
Westerink BHC, de Boer P, Damsma G (1990) Dopamine-acetylcholine interaction in the striatum studied by microdialysis in the awake rat: some methodological aspects. J Neurosci Methods 34: 117–124
Zetterström T, Sharp T, Ungerstedt U (1986) Effect of dopamine D1 and D2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo. Naunyn-Schmiedebergs Arch Pharmacol 334: 117–124
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dietze, S., Kuschinsky, K. Determination of extracellular glutamate after local K+ stimulation in the striatum of non-anaesthetised rats after treatment with dopaminergic drugs — studies using microdialysis. J. Neural Transmission 90, 1–11 (1992). https://doi.org/10.1007/BF01250513
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250513